News

Hosted on MSN7mon
Cigna to offer biosimilar to J&J’s arthritis drug Stelara at $0 out-of-pocket
Cigna's (NYSE:CI) pharmacy benefit manager, Evernorth Health Services, announced on Thursday plans to launch a biosimilar to Johnson & Johnson's (NYSE:JNJ) blockbuster arthritis therapy Stelara ...
Yahoo Finance25d
Celltrion's STEQEYMA® (ustekinumab-stba), now added to the Costco Member Prescription Program
JERSEY CITY, N.J., March 27, 2025 /PRNewswire/ -- Celltrion, Inc., today announced that STEQEYMA ® (ustekinumab-stba), a biosimilar to STELARA ... both subcutaneous injection and intravenous ...